ZNF224 and B-cell chronic lymphocytic leukemia: ZNF224 also behaves as a transcriptional activator in different cellular contexts, such as breast cancer and CLL, where it induces cell growth and apoptosis resistance through the transcriptional activation of miR-663 and cyclin D genes, respectively.